Skip to main content
AAgilent Technologies, Inc.Hold5.3·$171.74
A · Concentration risk · 10-K extracted

Agilent Technologies (A) concentration risks

Updated

The most significant concentration Agilent Technologies discloses is international operations, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Agilent Technologies’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 1 disclosed concentration

HIGH0
MEDIUM1
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

MEDIUMBuilt-inGeographic

international operations

“10-K Item 1A: 'revenue from international operations will continue to represent a majority of our total revenue'”
— SEC 10-K · filed Dec 2025
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-07-03

Agilent's only disclosed concentration is geographic: revenue from international operations is expected to continue representing a majority of total revenue. By disclosed size this is a medium-share exposure, and its character is structural — it reflects where the company's end-markets and instrument demand sit globally, not reliance on any individual customer, supplier, or product that could be withdrawn. Because the filing singles out no specific country, client, or counterparty, the exposure is diffuse rather than pinpointed: currency translation and broad regional macro cycles are the main channels through which it could affect reported results, and both tend to move gradually rather than abruptly. There is no disclosed customer, supplier, or product concentration layered on top of it to compound the effect. On balance, the disclosed concentration profile is narrow and well understood, and on its own is unlikely to move the investment verdict; it argues for monitoring foreign-exchange trends and international demand conditions rather than any single-name dependency.

For the engine’s reasoning on A’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Diagnostics & Research

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
ADPTAdaptive Biotechnologies Corpor2002
CRLCharles River Laboratories Inte1102
BLLNBillionToOne, Inc.1001
A●Agilent Technologies, Inc.0101
DGXQuest Diagnostics Incorporated0101
DHRDanaher Corporation0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home › Stocks › A › Concentration risk